137 related articles for article (PubMed ID: 31041182)
21. Hepatoprotective sesquiterpenes and rutinosides from Murraya koenigii (L.) Spreng.
Ma QG; Wang YG; Liu WM; Wei RR; Yang JB; Wang AG; Ji TF; Tian J; Su YL
J Agric Food Chem; 2014 May; 62(18):4145-51. PubMed ID: 24749720
[TBL] [Abstract][Full Text] [Related]
22. Extraction process optimization of
Sablania V; Bosco SJD; Bashir M
J Food Sci Technol; 2019 Dec; 56(12):5500-5508. PubMed ID: 31749498
[TBL] [Abstract][Full Text] [Related]
23. Study on antioxidant potential of Murraya koenigii leaves in Wistar rats.
Gill NS; Sharma B
Pak J Biol Sci; 2014 Jan; 17(1):126-9. PubMed ID: 24783791
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory activity of methanolic extract of Murraya koenigii (L) Spreng. leaves.
Shah AS; Wakade AS; Juvekar AR
Indian J Exp Biol; 2008 Jul; 46(7):505-9. PubMed ID: 18807753
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of in vitro aldose reductase inhibitory potential of alkaloidal fractions of Piper nigrum, Murraya koenigii, Argemone mexicana, and Nelumbo nucifera.
Gupta S; Singh N; Jaggi AS
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):255-65. PubMed ID: 24127538
[TBL] [Abstract][Full Text] [Related]
26. Phytochemical screening, total polyphenol, flavonoid content,
Abeysinghe DT; Kumara KAH; Kaushalya KAD; Chandrika UG; Alwis DDDH
Heliyon; 2021 Jul; 7(7):e07449. PubMed ID: 34286127
[TBL] [Abstract][Full Text] [Related]
27. Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.
Arun A; Patel OPS; Saini D; Yadav PP; Konwar R
Biomed Pharmacother; 2017 Sep; 93():510-521. PubMed ID: 28675857
[TBL] [Abstract][Full Text] [Related]
28. An update on Murraya koenigii spreng: a multifunctional Ayurvedic herb.
Gupta P; Nahata A; Dixit VK
Zhong Xi Yi Jie He Xue Bao; 2011 Aug; 9(8):824-33. PubMed ID: 21849142
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of nitric oxide scavenging activity of certain spices in vitro: a preliminary study.
Baliga MS; Jagetia GC; Rao SK; Babu K
Nahrung; 2003 Aug; 47(4):261-4. PubMed ID: 13678266
[TBL] [Abstract][Full Text] [Related]
30. Phytochemical and spectral analysis of the methanolic extracts of leaves of
Moni SS; Hadi Sultan M; Makeen HA; Jabeen A; Sanobar S; Siddiqui R; Ur Rehman Z; Alam MS; Ahmad S; Elmobark ME; Moochikkal R
Nat Prod Res; 2021 Aug; 35(15):2569-2573. PubMed ID: 31631708
[TBL] [Abstract][Full Text] [Related]
31. Alkenes with antioxidative activities from Murraya koenigii (L.) Spreng.
Ma QG; Xu K; Sang ZP; Wei RR; Liu WM; Su YL; Yang JB; Wang AG; Ji TF; Li LJ
Bioorg Med Chem Lett; 2016 Feb; 26(3):799-803. PubMed ID: 26777629
[TBL] [Abstract][Full Text] [Related]
32. Phytochemicals and Cytotoxicity of
Rawat P; Saroj LM; Kumar A; Singh TD; Tewari SK; Pal M
Pharmacogn Mag; 2016 Jul; 12(Suppl 4):S431-S435. PubMed ID: 27761070
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of bioactive carbazole alkaloids in Murraya koenigii.
Joshi T; Mahar R; Singh SK; Srivastava P; Shukla SK; Mishra DK; Bhatta RS; Kanojiya S
Nat Prod Commun; 2015 Feb; 10(2):293-5. PubMed ID: 25920265
[TBL] [Abstract][Full Text] [Related]
34. Murrayakoeninol--a new carbazole alkaloid from Murraya koenigii (Linn) Spreng.
Chakraborty M; Saha S; Mukhapadhyay S
Nat Prod Commun; 2009 Mar; 4(3):355-8. PubMed ID: 19413112
[TBL] [Abstract][Full Text] [Related]
35. Murraya koenigii (L.) Spreng. ameliorates insulin resistance in dexamethasone-treated mice by enhancing peripheral insulin sensitivity.
Pandey J; Maurya R; Raykhera R; Srivastava MN; Yadav PP; Tamrakar AK
J Sci Food Agric; 2014 Aug; 94(11):2282-8. PubMed ID: 24395372
[TBL] [Abstract][Full Text] [Related]
36. Augmented primary humoral immune response and decreased cell-mediated immunity by Murraya koenigii in rats.
Kaur I; Bhatia S; Bhati Y; Sharma V; Mediratta PK; Bhattacharya SK
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):211-5. PubMed ID: 24129104
[TBL] [Abstract][Full Text] [Related]
37. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
[TBL] [Abstract][Full Text] [Related]
38. Anti-Diabetic Potential of Murraya Koenigii (L.) and its Antioxidant Capacity in Nicotinamide-Streptozotocin Induced Diabetic Rats.
Husna F; Suyatna FD; Arozal W; Poerwaningsih EH
Drug Res (Stuttg); 2018 Nov; 68(11):631-636. PubMed ID: 29801176
[TBL] [Abstract][Full Text] [Related]
39. Positive inotropic effect of Murraya koenigii (Linn.) Spreng extract on an isolated perfused frog heart.
Shah KJ; Juvekar AR
Indian J Exp Biol; 2006 Jun; 44(6):481-4. PubMed ID: 16784119
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic biomonitored study of Euphorbia umbellata (Pax) Bruyns.
Luz LEC; Kanunfre CC; Paludo KS; da Silva Justo A; Petry VK; Lemes BM; Barison A; Nepel A; Wang M; Avula B; Khan IA; Beltrame FL
J Ethnopharmacol; 2016 May; 183():29-37. PubMed ID: 26906968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
